sibutramine has been researched along with Migraine Disorders in 1 studies
sibutramine: serotonin and norepinephrine transporter inhibitor; Meridia is tradename for sibutramine hydrochloride
Migraine Disorders: A class of disabling primary headache disorders, characterized by recurrent unilateral pulsatile headaches. The two major subtypes are common migraine (without aura) and classic migraine (with aura or neurological symptoms). (International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004: suppl 1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yilmaz, Y | 1 |
1 other study available for sibutramine and Migraine Disorders
| Article | Year |
|---|---|
Psychopathology in the context of obesity: the adiponectin hypothesis.
Topics: Adiponectin; Anxiety; Cyclobutanes; Depression; Headache; Humans; Migraine Disorders; Models, Biolog | 2008 |